Genpharma

[{"orgOrder":0,"company":"Genpharma","sponsor":"Orchard Therapeutics","pharmaFlowCategory":"D","amount":"Undisclosed","upfrontCash":"Undisclosed","newsHeadline":"Orchard Therapeutics Secures Partnerships to Broaden Access to LibmeldyTM for Eligible Patients in Middle East & Turkey","therapeuticArea":"Genetic Disease","highestDevelopmentStatus":"Approved","country":"","productType":"Cell and Gene therapy","productStatus":"Approved","date":"January 2021","year":"2021","type":"Collaboration","leadProduct":"Autologous CD34+ cell enriched HSPC","moa":"ARSA gene","url1":"","url2":"","graph1":"Genetic Disease","graph2":"Approved","graph3":"Genpharma","amount2":0,"therapeuticAreaNew":"Genetic Disease","highestDevelopmentStatusNew":"Approved","highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Genetic Disease","productSubType":"","amount2New":0,"dosageForm":"Dispersion for infusion","sponsorNew":"Genpharma \/ GenPharm","highestDevelopmentStatusID":"12","companyTruncated":"Genpharma \/ GenPharm"},{"orgOrder":0,"company":"Genpharma","sponsor":"Albireo Pharma","pharmaFlowCategory":"D","amount":"Undisclosed","upfrontCash":"Undisclosed","newsHeadline":"Albireo and Genpharm Announce Agreement to Commercialize Bylvay\u2122 (odevixibat) in Saudi Arabia and the Gulf Region","therapeuticArea":"Genetic Disease","highestDevelopmentStatus":"Approved","country":"","productType":"Small molecule","productStatus":"Approved","date":"August 2021","year":"2021","type":"Partnership","leadProduct":"Odevixibat","moa":"IBAT","url1":"","url2":"","graph1":"Genetic Disease","graph2":"Approved","graph3":"Genpharma","amount2":0,"therapeuticAreaNew":"Genetic Disease","highestDevelopmentStatusNew":"Approved","highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Genetic Disease","productSubType":"Small molecule","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Genpharma \/ Genpharm","highestDevelopmentStatusID":"12","companyTruncated":"Genpharma \/ Genpharm"}]